Skip to content

Amanda Marie Ferraro, MD

NPI 1073149001ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Oklahoma City, OK

Obstetrics & Gynecology, Reproductive Endocrinology (MD) in Oklahoma City, Oklahoma, licensed in OK, with an NPI issued in March 2020. Part D covered 15 prescriptions written in 2024, 93% of them generic. Ferring Pharmaceuticals Inc. reported $106.30 in payments in 2025, mostly food and beverage.

Overview

NPI1073149001
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 21, 2020
Last updated in NPPESJun 18, 2024
Certified by providerJun 18, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Obstetrics/Gynecology (OK)

Part D prescriptions in 2024

Prescriptions (claims)15 · 15 30-day fills
Total drug cost$104.62
Generic share93% of claims

Medicare sources and data years

Education and affiliations

Graduation year2020
Medicare specialtyObstetrics/Gynecology

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$106.30 · 1 payment from 1 company
  • 2024$1,294 · 4 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$106.301

What the 2025 payments were for

  • Food and Beverage$106.30 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Oklahoma City

All Obstetrics & Gynecology, Reproductive Endocrinology providers in Oklahoma →